rotate-mobile
Venerdì, 19 Aprile 2024
Salute

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression



In Evidenza

Potrebbe interessarti

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

Today è in caricamento